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Tuberculosis is a rampant infectious pandemic worldwide, with an annual incidence of 8
million active cases and 2 million deaths. Tuberculosis is also among the leading causes of
solitary pulmonary nodule in the tropics. Although lymph nodal masses are common in
tuberculosis, parenchymal masses are distinctly rare. We report eight immunocompetent
adults admitted with large pulmonary masses, and ultimately diagnosed to have
parenchymal pseudotumoral tuberculosis. Clinical and radiological resolution followed
anti-tubercular therapy alone. We have also conducted a MEDLINE search and summarize
the clinical features of all patients with parenchymal pseudotumoral tuberculosis. We also
compare our findings with published literature and discuss the possible mechanisms
leading to large inflammatory masses, clinical and radiologic clues to the same, common
errors in clinical decision making and the therapy of this rare entity.
& 2007 Elsevier Ltd. All rights reserved.Introduction
Tuberculosis is a global emergency and is the leading cause
of deaths due to infectious disease worldwide. The
radiological manifestations are easily recognized. Primary
tuberculosis presents as consolidation with or without
lymphadenopathy. Atelectasis, pleural effusions and miliary
pattern are other presenting features of primary tubercu-
losis. Post-primary tuberculosis presents with non-homo-Elsevier Ltd. All rights reserved.
2756825;
com, ritesh@indiachest.orggenous opacities or cavities in the apical or posterior
segment of the right upper lobe or apical segment of
lower lobe. Several unusual radiographic features are
well described.1–4 In primary disease, these include lym-
phadenopathy without infiltrates; lower lobe infiltrates
without adenopathy or effusion; solitary tuberculoma
and occurrence of primary disease in patients aged
more than 40 years.1–3 In post-primary disease, non-
homogeneous opacities in the lower lobes or anterior
segment of upper lobes, mass lesions simulating neoplasms,
isolated bronchopleural fistula and normal radiographs are
atypical.2,5 With decreasing disease burden and change
in disease epidemiology, these ‘‘unusual manifestations’’
are generally forgotten, and thus may cause diagnostic
dilemma.
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Parenchymal pseudotumoral tuberculosis 383Although lymph nodal masses are not uncommonly
encountered in tuberculosis, parenchymal masses are
distinctly rare in tuberculosis and have been variably
reported as occurring in primary and post-primary tubercu-
losis. Herein, we report eight immunocompetent adults who
presented with large masses and were diagnosed to have
parenchymal post-primary pseudotumoral tuberculosis. We
have also conducted a MEDLINE search on this rare
presentation and supplemented this by hand search of
literature and our personal records.Methods
Case series
The computer records of patients admitted from April 2002
to December 2006 to the pulmonary medicine ward of this
institute with a diagnosis of tuberculosis were reviewed.
Patients with the discharge diagnosis of pseudotumoral
tuberculosis, tuberculosis and mass were selected. The
original case records of the patients were then retrieved
from the central registration department. Demographic
information such as age and gender, clinical status at
admission were recorded. Details of the clinical manifesta-
tions and investigations like computed tomography (CT),
bronchoscopy, fine needle aspiration cytology (FNAC), trucut
biopsies were also recorded.
Patients were included if they met the following criteria:
(1) one or more mass of at least 3 cm and one of the
following four findings on investigation—(a) histopathology
showing acid-fast bacilli (AFB) and epithelioid granulomas or
(b) granulomatous inflammation (AFB negative) and com-
plete response to anti-tubercular therapy (ATT) alone or (c)
biopsy specimen positive for Mycobacterium tuberculosis on
culture or (d) sputum positive for AFB or sputum cultures
growing M. tuberculosis.Literature review
Two of the authors (RS and RA) independently conducted a
MEDLINE search using the terms tuberculosis and mass,
pseudotumoral tuberculosis, tuberculosis and carcinoma
lung in the English literature between 1964 and December
2006 and supplemented this by hand search of literature and
personal records. Parenchymal pseudotumoral tuberculosis
was defined by the presence of one or more masses of at
least 3 cm. The individual cases were reviewed and available
data regarding clinical presentation, radiographic findings,
management and outcomes were extracted. Lymph nodal
pseudotumoral tuberculosis was not included for data
analysis. Data of the current series was then compared with
earlier published literature.Statistics
The statistical package Stats Direct (Stats Direct version
2.6.2 for MS-Windows, England, Stats Direct Ltd., 2005.
http://www.statsdirect.com) was used to perform the
statistical analysis. Epidemiological and outcome para-meters of the patients are presented in a descriptive fashion
(mean7SD or median with range).Results
During the four-and-half-year period, 1286 (822 male and
464 female patients) patients were admitted which included
234 admissions of patients with tuberculosis. Of the 234
admissions with tuberculosis, we identified 8 (3.4%) patients
with histopathologically confirmed diagnosis of parenchymal
pseudotumoral tuberculosis (Table 1). The mean (SD) age was
36 (713.6) with a range of 20–55 years (Table 2). These
include five males and three female patients (M:F ¼ 5:3). All
patients were immunocompetent and non-reactive for hu-
man immunodeficiency virus by enzyme linked immunoassay;
anti-nuclear and anti-neutrophil cytoplasmic antibody
(ANCA) were also negative by indirect immunofluorescence.
Serum biochemistry, complete blood counts and urinalysis
were normal in all patients. All patients were positive on
tuberculin testing (Mantoux test) at onset (median
15 17mm, range 12 10mm to 25 18mm). Most were
non-smokers (5/8) and presented after a mean (SD) delay of
16 (711.9) weeks from onset of symptoms. Non-productive
cough (100%), constitutional symptoms (75%) and dyspnea
(50%) were the most common presenting symptoms (Table 1).
Fever and hemoptysis were present in two patients only
(25%). There were a total of eight masses, six on the right
and two on the left side (R:L ¼ 3:1). Most masses were large
and involved more than one segment (Figures 1–4; the
radiology of individual patients is provided as an online
supplement file). The anterior segment and the apical
segment of the right upper lobe were the most common site
for pulmonary mass (62.5%, 5/8 each), followed by the apical
segment of right lower lobe (50%, 4/8) and the lingula
(Table 1). Centrilobular nodules, often with ‘‘tree-in-bud’’
sign, were seen along with the mass on high-resolution
computed tomography (37.5%, 3/8). Cavitation was seen in
50% (4/8) of the masses. Lymphadenopathy (2/8, 25%) and
was infrequent and calcification was not observed. Sponta-
neous pneumothorax was seen in one patient. Percutaneous
FNAC (2/5, 40%) and trucut biopsy (2/3, 66%) were used
more frequently to achieve diagnosis. Bronchoscopy was
abnormal in 75% (6/8) but yielded the diagnosis only in two
patients (2/8, 25%). Sputum was positive for AFB in two
patients (25%). More than one modality was used often for
diagnosis (6/8, 75%). One patient was recognized to have this
rare presentation only after the surgical biopsy specimen
showed granulomatous inflammation with AFB (broncho-
scopy, FNAC and trucut biopsy did not yield a diagnosis). All
patients showed resolution with anti-tubercular drugs (iso-
niazid 600mg, rifampicin 600mg, pyrazinamide 1500mg and
ethambutol 1200mg thrice a week for 2 months followed by
isoniazid 600mg and rifampicin 600mg thrice a week for 4
months) administered as directly observed therapy under the
revised national tuberculosis control program and none
received steroids. In three patients, therapy was extended
to 8 months due to clinical and radiological non-resolution.
The mean duration of therapy administered was 27 weeks
(range 24–32 weeks). Residual fibrosis was observed in three
patients (37.5%, 3/8). All patients were asymptomatic at
follow-up with no significant sequelae.
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Table 1 Clinical features of parenchymal pseudotumoral tuberculosis.
S.
no.
Age Sex Duration
of
symptoms
(weeks)
Symptoms Site of mass Size
of
mass
(cm)
Associated radiologic
findings
Method of diagnosis
1 20 M 20 Cough, dyspnea Large mass
RUL and apical
segment of RLL
11 9 Pneumothorax Bronchoscopy—N,
BALFTBLB:
granuloma, AFB /
culture +
2 24 M 16 Cough,
constitutional
symptoms,
anorexia
RUL apical,
anterior
segment mass
9 6 Necrosis, cavitation,
RML atelectasis, hilar
nodes, satellite
nodules RUL
FNAC/BALF ;
EBBx granuloma,
AFB +
3 24 M 4 Cough,
constitutional
symptoms, fever,
anorexia, chest
pain
LUL apico-
posterior and
LLL apical,
inferior lingula
5 3 Nil FNAC: granuloma;
AFB  trucut Bx:
granuloma +
clinical response
4 41 F 24 Cough, dyspnea RUL to RLL
apico-
posterior mass
8 6 Nodules, tree-in-
bud, cavitation
Induced sputum
AFB +
5 46 F 40 Cough,
hemoptysis,
constitutional
symptoms
RUL apical,
anterior
segment mass
6 5 Nil FNAC /BALF ;
EBBx granuloma +,
AFB ; response +
6 28 M 8 Cough, dyspnea,
hemoptysis
RLL apical
segment mass
5 6 Collapse, hilar and
subcarinal nodes
Bronchoscopy N;
FNAC /trucut Bx
granuloma +
culture +
7 55 M 8 Cough, fever,
constitutional
symptoms
RUL, RLL
apico-
posterior mass
7 8 Nodules, tree-in-
bud, cavitation
FNAC /EBBx ;
trucut-surgical
specimen
granuloma +/
culture +
8 50 F 8 Cough, dyspnea,
expectoration,
anorexia
LUL anterior
segment/
lingula
10 4 Collapse, cavitation Sputum AFB +
Abbreviations: AFB: acid-fast bacilli; ATT: anti-tubercular therapy; BALF: bronchoalveolar lavage fluid; EBBx: endobronchial biopsy;
FNA: fine needle aspiration; LUL: left upper lobe; N: normal; PCR: polymerase chain reaction; RLL: right lower lobe; RML: right middle
lobe; RUL: right upper lobe; : negative; +: positive.
R. Agarwal et al.384Review of reported literature3,6–10 showed marked het-
erogeneity in the site, size of parenchymal masses and
diagnostic method employed (Table 2). Of the total of 36
masses in 35 patients, the right side was preferentially
involved (18:7, N ¼ 25) and the upper lobe was the most
common site involved 52.7% (19/36 masses). The most
common segment involved in the upper lobe was the right
apical segment. Atelectasis and centrilobular nodules
(27.8%, 10/36) were variably described but cavitation,
calcification and adenopathy were distinctly rare. The
method of diagnosis was available for review in 31 cases.
Bronchoscopic biopsy and FNAC were the most common
diagnostic modalities but sputum AFB, bronchoalveolar
lavage fluid (BALF) AFB (total 29.1%, 9/31 cases) and
surgical biopsy (22.5%, 7/31) were also used. Most patients
responded to ATT alone and data on steroids or other
adjunctive therapy was not available. Data on follow-up waslacking (14 cases only), and residual fibrosis developed in
five of these (5/14, 35.7%) (Table 2).Discussion
Tuberculosis is a global emergency and is the leading cause
of deaths due to infectious disease worldwide.11 India
accounts for 1.8 million new cases and 370,000 deaths each
year.12 With such a huge burden, the pre-test probability of
pulmonary tuberculosis for any thoracic lesion is sufficiently
high. On the other hand, lung cancer is among the most
common adult cancers and is increasing in incidence. Most
patients in developing countries present with advanced
disease and large masses.13 In fact, the admitting diagnosis
was not tuberculosis in any of our patients and four patients
were admitted with a provisional diagnosis of lung cancer.
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Table 2 Clinical features, investigations and outcome of all patients with parenchymal pseudotumoral tuberculosis reported
in English literature.
Parameter Observed
value
Cherian et al.7,8 Miller et al.3 Woodring et al.6 Others9,10
Demographic characteristics
No. of cases 8 13 7 4 3
Age (mean7SD) 36 (713.6)
years
34.7 (718.6) NA NA 61.3
(715.6)
Sex (M:F) 5:3 10:3 0:3
Time to
presentation after
symptoms (weeks)
15.7 (range
4–40) weeks
NA 4 weeks
Symptoms, N (%)
Cough 8(100) 12 (92.3) NA (all described as
progressive primary
tuberculosis)
NA (all described as post-
primary tuberculosis)
2 (66.6)
Constitutional
symptoms
6 (75) 6 (46) 3 (100)
Dyspnea 4 (50) 2 (15.4) 1 (33.3)
Loss of appetite or
weight
3 (37.5) 4 (30.8) 3 (100)
Fever/hemoptysis 2 (25) 2 (15.4) 1 (33.3)
Mode of diagnosis, N (%)
Fine needle
aspiration
2/5 (40) 5 (38.5) Individual diagnostic
modality of 7 cases NA;
included surgical
biopsies (5/7)
Individual diagnostic
modality NA
None
Percutaneous
trucut biopsy
2/3 (66.6) NA None
Bronchoscopic
biopsy
2/5 (40) 1/7 (7.7) 3 (100)
Others Induced
sputum AFB
(2/5), Surgical
biopsy (1)
Sputum or BAL
4/13, empiric
1/13, Post-op
biopsy (1)
None
Pathological/microbiological findings, N (%)
Histopathology/
culture
6/8, 2/8 7/13, 6/13 5/7, 1/7 56 cases post-primary TB,
53 sputum AFB,
bronchoscopy2
2/3, 0
Epitheloid
granuloma7necrosis
only
4/6 (66) N/A 0/5 1 (33.3)
Granuloma and
AFB+
2/6 (34) N/A 5/5 (100) None
Culture+ for M.
tuberculosis
2/8 (25) N/A 5/5(100) 2/3
(66.6)
Radiology findings, N (%)
Site of mass R:L 6:2 9:5 Right predominant Right predominant 3:0
Most common site (R) UL,
anterior and
apical
segment
(R) LL, basal
segment
(R) UL post seg (2/7),
LL (2/7), anterior seg
(1/7), lingula (1/7), ML
(1/7) NA
UL in all 4 cases. Size NA.
One case described as
2 cm (would be classified
as nodule)
(R) UL
anterior
seg (2/3)
Median size of
mass
5.5 4 (range
4 3 to
10 4) cm
4.5 3.1 (3 4
to 9.5 5) cm
NA
Associated
atelectasis
25% (2/8) 15.5% (2/13) 66.6%
(2/3)
Cavitation 50% (4/8) 7.7.% (1/13) 0%
Hilar
lymphadenopathy
25% (2/8) 7.7% (1/13) 0% 0% 0%
Mediastinal
lymphadenopathy
12.5% (1/8) NA 0%
Parenchymal pseudotumoral tuberculosis 385
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Table 2 (continued )
Parameter Observed
value
Cherian et al.7,8 Miller et al.3 Woodring et al.6 Others9,10
Presence of
centrilobular
nodules, tree-in-bud
37.5% (3/8) 15.4% (2/13) Evaluation on basis of
frontal radiography
only
100% (4/4) 33.3%
(1/3)
Others Pneumothorax
12.5% (1/8)
Effusion (7.7%),
calcification
(7.7%)
NA Collapse
(66.6%)
Bronchoscopy findings, N (%)
Abnormal 6/8 83.3%
(5/6)
4/13 NA 0/7 Not done/reported Individual details NA;
either sputum or BALF
AFB+ in all 4 cases
100%
(yielded
diagnosis
in all)
Endobronchial
abnormality
60% (3/5) 7.7% (1/13) 100%
Extrinsic
compression/edema
40% (2/5) NA NA
Outcome, N (%)
Response to ATT
alone
100% (7/7) Initial response
100%, follow up
data 46%
NA NA 100%
Residual fibrosis 37.5% (3/8) Fibrosis 15%
(2/13)
NA NA None
Abbreviations: AFB: acid-fast bacilli; ATT: anti-tubercular therapy; BALF: bronchoalveolar lavage fluid; LL: lower lobe; ML: middle
lobe; NA: not available; UL: upper lobe.
Figure 1 Chest radiograph shows a large mass occupying
almost the entire right hemithorax. Also seen are two air fluid
levels due to secondary pneumothorax which resulted after a
ultrasound guided fine needle aspiration which resolved
spontaneously.
R. Agarwal et al.386The distinction of nodules from masses on the basis of size
is primarily because size is a predictor of malignancy.14 The
aim of evaluation is to recognize malignancy while avoidingmorbidity in the majority. With larger sizes (masses more
than 3 cm), the probability of malignancy is so high that
absence of smoking, young age, calcification may still not
predict benign etiology. However, tuberculosis may present
with protean manifestations and has been reported to mimic
both benign and malignant tumors.15
A pseudotumor of the lung is composed of inflammatory
cells and showing complete maturity of fibroblastic compo-
nents with a striking lack of mitosis. The distinction of these
masses from tuberculomas has been detailed previously.8
Mechanistically, tubercular pseudotumoral masses may be
due to conglomerate nodes (lymph nodal pseudotumor) or
parenchymal granulomatous mass. These are pathogeneti-
cally distinct and evolution may depend on whether the
disease is primary or post-primary tuberculosis. The distinc-
tion between primary and post-primary disease is often
arbitrary and is based on age, tuberculin testing and
radiological features. Lymph nodal masses denote primary
infection invariably, in the absence of significant immuno-
deficiency. In post-primary tuberculosis, the interplay of
host immunity and mycobacterial virulence determines the
radiological features. Tubercular caseous material drains
into a bronchus, forms a cavity, reaching a new host.16 In the
absence of bronchial rupture and decompression, enlarging
necrotic areas may form large parenchymal masses. This has
been variably reported to occur in progressive primary
tuberculosis7,8 and post-primary tuberculosis as well.6
Predominant endobronchial involvement may simulate
malignancy endoscopically and is commonly reported. Large
parenchymal masses are, however, extremely uncommon
ARTICLE IN PRESS
Figure 2 Computed tomography shows a large mass 11 9 cm with areas of cavitation occupying the right upper and middle lobe
and the apical segment of the right lower lobe.
Figure 3 Computed tomography shows a heterogeneously attenuating mass measuring 9 6 cm occupying the right upper lobe
apical and anterior segment.
Parenchymal pseudotumoral tuberculosis 387and may mimic malignancy clinically, endoscopically and
radiologically.8
Data on such parenchymal masses is rare. In several large
series of patients with post-primary tuberculosis, no mass-
like opacities were seen.2 From our search we identified
1389 citations out of which 72 were related to tuberculosis
complicating bronchogenic carcinoma; 13 citations related
to pseudotumoral forms at other sites17–29 and 18 related to
pseudotumoral pulmonary tuberculosis. Of the 18 refer-ences, only 6 citations (including 27 cases) reported
parenchymal pseudotumoral tuberculosis3,6–10 (Tables 1
and 2). Thus, presentation of tuberculosis as large parench-
ymal masses in healthy immunocompetent adults is dis-
tinctly rare.
The location of parenchymal masses has been variably
reported as upper lobe3,6 or lower lobe predominant8
earlier. This disparity is likely to represent masses develop-
ing as a complication of progressive primary or post-primary
ARTICLE IN PRESS
Figure 4 Computed tomography lung windows show the same mass as in Figure 3 in the right upper lobe apical and anterior segment
(left). Also seen are centrilobular nodules and occasional tree-in-bud pattern (right, arrow).
R. Agarwal et al.388tuberculosis. The preference of primary tubercular infection
for the lower lobes is because of greater ventilation therein;
impaired lymph drainage and better oxygenation in the
upper lobes favor re-activation tuberculosis. In fact, given
the high rates of infection in the tropics, the mean age of
the patients and the positive tuberculin testing at onset, the
upper lobe predominance of most cases is obvious. While the
apical segment of the right upper lobe is the most common
site, the anterior segment is also involved3,8 and the
anterior segment of the upper lobe was involved in 46% of
post-primary tuberculosis.30 Observed clinical features,
including hemoptysis, centrilobular nodules and cavitation
could also vary depending on primary or post-primary
infection. The presence of centrilobular nodules, though
uncommon, implies airway spread, suggesting tuberculosis
and predicting a greater yield of sputum AFB and broncho-
scopy. Absence of AFB in smear, centrilobular nodules on
imaging, pulmonary masses, upper respiratory symptoms or
abnormal urinalysis should also prompt exclusion of ANCA-
related vasculitis, given the reported response of an
occasional case of Wegener’s granulomatosis to anti-tuber-
cular therapy alone.31 Data on therapy of pseudotumoral
tuberculosis is scant. All our patients showed complete
resolution with short-course anti-tubercular chemotherapy.
While therapy is often prolonged on clinical grounds
empirically in smear-negative and extra-pulmonary tuber-
culosis, data on optimum duration of therapy of pseudotu-
moral parenchymal tuberculosis is unavailable from the
published literature because of its rarity. The role of
steroids and surgery is unclear. In the event of radiological
non-resolution, surgical lung biopsy is indicated to rule out
associated bronchogenic carcinoma.32
Heuristics are learned shortcuts that all physicians use to
solve complex clinical problems.33 Despite being quite
useful, they may contribute to diagnostic errors. Clinicians
may fall a prey to a common type of cognitive bias—repre-
sentativeness heuristics. The probability of carcinoma lung
in a middle aged smoker presenting with hemoptysis,
anorexia, weight loss and lung mass is high. This bias is
strengthened when fever is absent and radiology is
suggestive; an alternative competing diagnosis is thus not
considered. Availability heuristic states that new events areeasily grouped cognitively with memorable previous experi-
ences that are similar in some detail or pattern to the
present event.33 While it may contribute to recall bias, it
may contribute to evaluation by suggesting an alternative
competing diagnosis; tuberculosis, in this case. Clinicians
can reduce errors in clinical decision making by balancing
competing biases.34 Wider appreciation of parenchymal
pseudotumoral tuberculosis is necessary to prevent over-
evaluation, prevent ‘‘premature closure’’ and administer
timely therapy.
The limitations of this study includes the retrospective
nature of the study and the fact that only admitted patients
were evaluated and it may be possible that some cases that
have undergone diagnostic evaluation in the outpatient
clinic might have been missed. The strength of this study is
the fact that the index data have been compared with the
available evidence using a systematic search of the
literature.Conclusions
In conclusion, the myriad presentations of tuberculosis
continue to challenge physicians’ diagnostic skills. Parench-
ymal pseudotumoral tuberculosis is a rare entity, with about
27 cases reported in English literature. Most patients
present with non-productive cough and constitutional
symptoms. Diagnosis may be difficult, given the pauci-
bacillary nature of the disease and high index of suspicion
with use of multiple diagnostic modalities is often needed.
Clinicians can reduce errors in clinical decision making by
balancing competing biases in decision making. Current
medical literature often contributes to this, by dissemina-
tion of knowledge of rarer presentations of common clinical
problems.Conflict of interest
The authors declare that they have no conflict of interest in
the manuscript or any financial disclosure.
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Supplementary data associated with this article can be
found in the online version at doi:10.1016/j.rmed.2007.
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